USE OF MURAGLITAZAR FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR TREATING SKIN DISORDERS

摘要

The invention relates to the use of at least one compound selected from [[(4-methoxyphenoxy)carbonyl] [4-[2-(5-methyl-2-phenyloxazol-4- yl)ethoxy]benzyl]amino]acetic acid (muraglitazar) and the pharmaceutically acceptable salts thereof, for preparing a pharmaceutical composition for the treatment of skin disorders.